Clinical Trial Update: N-Acetylcysteine Roles in Preserving Renal Function Measured by Urinary KIM-1 (Kidney Injury Molecule-1) and Serum Creatinine on Cancer Patients With Cisplatin Based Chemotherapy: A Randomized Placebo-Controlled Trial [Phase 2, Phase 3]

View source ↗

Summary

A randomized, placebo-controlled trial is planned to evaluate whether N-Acetylcysteine can preserve renal function in cancer patients receiving cisplatin-based …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Solid Tumors

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Fakultas Kedokteran Universitas Indonesia | Conditions: Kidney Function Issue, Acute Kidney Injury | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING